Manifestations and Management of Difficult-to-Treat Psoriasis

被引:24
|
作者
Aldredge, Lakshi M. [1 ]
Higham, Robert C. [2 ]
机构
[1] VA Portland Hlthcare Syst, 3710 S WUS Vet Hosp Rd, Portland, OR 97239 USA
[2] Amer Skin Inst, Sherman Oaks, CA USA
关键词
Difficult-to-Treat Psoriasis; Facial Psoriasis; Inverse Psoriasis; Nail Psoriasis; Palmoplantar Psoriasis; Scalp Psoriasis;
D O I
10.1097/JDN.0000000000000418
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis is a common, immune-mediated skin disorder that can manifest as multiple clinical phenotypes. Although psoriasis affecting the scalp, face, nails, palms, soles, and intertriginous regions has not been studied as extensively as chronic plaque psoriasis in other body areas, these phenotypes can be associated with significant physical, psychosocial, and functional impairments, which impact quality of life. In addition, recent evidence has shown that psoriasis affecting these areas is more prevalent than traditionally thought. In this article, we discuss the clinical characteristics of these hard-to-treat areas and review newer treatment options, which have shown significant efficacy for psoriasis affecting these body regions. To provide optimal care to patients with difficult-to-treat psoriasis, nurses, nurse practitioners, and physician assistants should evaluate patients for scalp, facial, nail, palmoplantar, and inverse psoriasis to provide more effective therapeutic options.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 50 条
  • [1] Management of patients with difficult-to-treat psoriasis in Africa and the Middle East
    Steinhoff, Martin
    Ammoury, Alfred F.
    El Sayed, Mahira H.
    Nassier, Reenad
    Tarcha, Nadine
    Mounir, Mohamed
    Al Saif, Fahad M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB91 - AB91
  • [2] Efficacy and safety of adalimumab in difficult-to-treat psoriasis
    Lanna, Caterina
    Zangrilli, Arianna
    Bavetta, Mauro
    Campione, Elena
    Bianchi, Luca
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [3] Use of Biologic Therapeutics in Difficult-to-Treat Psoriasis
    Lynde, Charles
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 (01) : 6 - 17
  • [4] The legs: An underestimated difficult-to-treat area of psoriasis
    Bardazzi, Federico
    Viviani, Filippo
    Filippi, Federica
    Carpanese, Miriam Anna
    Piraccini, Bianca Maria
    Abbenante, Diego
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (06)
  • [5] Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
    Nicolescu, Alin Codrut
    Ionescu, Marius-Anton
    Constantin, Maria Magdalena
    Ancuta, Ioan
    Ionescu, Sinziana
    Niculet, Elena
    Tatu, Alin Laurentiu
    Zirpel, Henner
    Thaci, Diamant
    [J]. LIFE-BASEL, 2022, 12 (12):
  • [6] Management of difficult-to-treat depression with anxiety
    Papakostas, George
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 324 - 324
  • [7] Management of difficult-to-treat inhibitor patients
    Giangrande, P. L. F.
    Escobar, M. A.
    [J]. HAEMOPHILIA, 2010, 16 : 52 - 57
  • [8] Management of Difficult-to-Treat Atopic Dermatitis
    Arkwright, Peter D.
    Motala, Cassim
    Subramanian, Hamsa
    Spergel, Jonathan
    Schneider, Lynda C.
    Wollenberg, Andreas
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (02): : 142 - 151
  • [9] Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas
    Kivelevitch, Dario
    Frieder, Jillian
    Watson, Ian
    Paek, So Yeon
    Menter, M. Alan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (06) : 561 - 575
  • [10] Difficult-to-Treat and Severe Asthma: Management Strategies
    Narasimhan, Krishnan
    [J]. AMERICAN FAMILY PHYSICIAN, 2021, 103 (05) : 286 - 290